Questcor (NASDAQ: QCOR) is a smaller player in the biotech space that has garnered a lot of attention on Fool.com. In this video, Motley Fool health-care bureau chief Brenton Flynn talks about his recent look through the SEC filings of this company, and some of the less-reported information that he found. One play the company is making: a move toward pushing for another indication, rheumatology, which the company is already moving a sales force behind.